Total Payments
$768.90
2024 Payments
$86.84
Companies
12
Transactions
37
Medicare Patients
4,936
Medicare Billing
$253,054
Payment Breakdown by Category
Food & Beverage$768.90 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $768.90 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $206.89 | 12 | $0 (2024) |
| ABBVIE INC. | $139.68 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $136.43 | 2 | $0 (2022) |
| PFIZER INC. | $87.40 | 2 | $0 (2023) |
| Amgen Inc. | $62.27 | 4 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $27.30 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.73 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $23.47 | 1 | $0 (2024) |
| Lundbeck LLC | $16.58 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.33 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.84 | 4 | Novo Nordisk Inc ($63.37) |
| 2023 | $195.64 | 9 | PFIZER INC. ($87.40) |
| 2022 | $388.95 | 18 | AstraZeneca Pharmaceuticals LP ($136.43) |
| 2021 | $97.47 | 6 | AbbVie Inc. ($58.10) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Biological | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Obesity | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Bone Health | ||||||
| 10/26/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Hematology | ||||||
| 08/14/2023 | PFIZER INC. | COMIRNATY (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: VACCINES | ||||||
| 05/01/2023 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $59.21 | General |
| Category: VACCINES | ||||||
| 04/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Diabetes | ||||||
| 03/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 01/23/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 11/28/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 09/21/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 08/08/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: DIABETES | ||||||
| 07/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes | ||||||
| 06/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Bone Health | ||||||
| 03/24/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Gastroenterology | ||||||
| 03/23/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: NEUROLOGY | ||||||
| 03/21/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,911 | 2,722 | $266,707 | $104,949 |
| 2022 | 34 | 2,119 | 2,892 | $290,827 | $107,347 |
| 2021 | 19 | 906 | 991 | $95,683 | $40,758 |
Total Patients
4,936
Total Services
6,605
Medicare Billing
$253,054
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 296 | $71,040 | $23,620 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $24,335 | $19,402 | 79.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 52 | 52 | $18,615 | $14,379 | 77.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 171 | $25,650 | $8,273 | 32.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 74 | 75 | $5,250 | $5,145 | 98.0% |
| 77067 | Screening mammography | Office | 2023 | 51 | 51 | $15,300 | $4,454 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 51 | $7,650 | $3,028 | 39.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 184 | 340 | $3,400 | $2,848 | 83.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 173 | 269 | $18,830 | $2,784 | 14.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 77 | $2,310 | $2,264 | 98.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 65 | 78 | $6,396 | $2,263 | 35.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 145 | 170 | $12,750 | $2,208 | 17.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 168 | 259 | $6,475 | $1,971 | 30.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 22 | $4,840 | $1,839 | 38.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 78 | 103 | $5,356 | $1,695 | 31.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $4,800 | $1,594 | 33.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 40 | 40 | $13,200 | $1,447 | 11.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 88 | 139 | $4,865 | $1,304 | 26.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 52 | 52 | $1,300 | $1,274 | 98.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 20 | 22 | $2,420 | $1,254 | 51.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 31 | 31 | $1,705 | $586.52 | 34.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 34 | 36 | $2,808 | $532.08 | 18.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 59 | $3,068 | $484.65 | 15.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 13 | 17 | $850.00 | $140.93 | 16.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 19 | 27 | $594.00 | $83.97 | 14.1% |
About Dr. Renessa Gerhardt, MD
Dr. Renessa Gerhardt, MD is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1790216224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renessa Gerhardt, MD has received a total of $768.90 in payments from pharmaceutical and medical device companies, with $86.84 received in 2024. These payments were reported across 37 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($768.90).
As a Medicare-enrolled provider, Gerhardt has provided services to 4,936 Medicare beneficiaries, totaling 6,605 services with total Medicare billing of $253,054. Data is available for 3 years (2021–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 03/26/2017
- Last Updated 08/11/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1790216224
Products in Payments
- FARXIGA (Drug) $136.43
- Rybelsus (Drug) $125.19
- LINZESS (Drug) $97.28
- EVENITY (Biological) $62.27
- PREVNAR 13 (Biological) $59.21
- Ozempic (Drug) $45.84
- COMIRNATY (Biological) $28.19
- Kerendia (Drug) $27.30
- UBRELVY (Drug) $26.76
- JARDIANCE (Drug) $24.73
- Veozah (Drug) $23.47
- Wegovy (Drug) $23.13
- VYEPTI (Biological) $16.58
- XIFAXAN (Drug) $16.33
- ACCRUFER (Drug) $15.75
- VRAYLAR (Drug) $15.64
- Saxenda (Drug) $12.73
- TRULICITY (Drug) $12.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681